Jakob Loven
Co-Founder and Managing Partner at Juvia Group
Sweden
Jakob Loven, Co-Founder and Managing Partner at Juvia Group is an active investor based in Sweden. This profile covers what Jakob Loven backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEInvestor
- Stages
- Seed
- Invests in
- Healthcare & BiotechBiotech & PharmaIoT & Connected DevicesGaming & EntertainmentMedia & ContentTravel & Hospitality
- Location
- Sweden
- Typical check
- $250K
- Past investments
- 44
Notable investments
Black Diamond Therapeutics
Blueprint Medicines
Boundless BioKronos Bio, Inc.
TRACON PharmaceuticalsJounce TherapeuticsKinnate Biopharma, Inc.
Peloton Therapeutics
ArvinasCullinan OncologySilverback Therapeutics
Sunesis PharmaceuticalsHow to reach Jakob Loven
Angels and operators like Jakob Loven reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Jakob Loven
Frequently Asked Questions
What does Jakob Loven invest in?
Jakob Loven invests in Healthcare & Biotech, Biotech & Pharma, IoT & Connected Devices and Gaming & Entertainment, typically at Seed. Match your sector and stage, then reach out with a personalized pitch.
What stage does Jakob Loven invest at?
Jakob Loven typically invests at Seed. Lead with traction that fits the stage when you reach out.
What is Jakob Loven's typical check size?
Jakob Loven typically writes checks around $250K. Use it as a signal for whether your raise fits their stage.
How do I contact Jakob Loven?
Unlock Jakob Loven's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.